Related Experiment Video
Updated: Nov 13, 2025

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Long-term Outcomes in Asymptomatic Ulcerative Colitis Diagnosed During Screening Colonoscopy
Takeshi Okamoto1, Katsuyuki Fukuda1
1Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan.
Treatment goals for ulcerative colitis now focus on histological remission, moving beyond clinical remission and mucosal healing. Achieving histological remission offers patient benefits, though clinical, endoscopic, and histological measures may not align.
Area of Science:
- Gastroenterology and Inflammatory Bowel Disease Research
Background:
- Ulcerative colitis (UC) treatment goals have evolved significantly.
- Initial goals focused on clinical remission, progressing to mucosal healing, and now emphasizing histological remission.
- Evidence suggests treating patients with healed mucosa is clinically advantageous.
Purpose of the Study:
- To highlight the shift in therapeutic targets for ulcerative colitis.
- To underscore the importance of histological remission as a primary treatment objective.
- To discuss the implications of achieving histological remission in UC management.
Main Methods:
- Review of current literature and treatment guidelines in ulcerative colitis.
- Analysis of the correlation between clinical, endoscopic, and histological outcomes.
- Synthesis of evidence supporting the benefits of achieving histological remission.
Main Results:
- Clinical remission, mucosal healing, and histological remission represent a progressive hierarchy of UC treatment goals.
- Histological remission is increasingly recognized as a critical endpoint in UC therapy.
- Discrepancies exist between clinical, endoscopic, and histological assessments, indicating the need for integrated evaluation.
Conclusions:
- The paradigm for ulcerative colitis management has advanced to prioritize histological healing.
- Achieving histological remission is associated with improved long-term outcomes for UC patients.
- A comprehensive assessment integrating clinical, endoscopic, and histological data is crucial for optimal UC treatment.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Endoscopic Procedures II: Colonoscopy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

